Inactive Instrument

News ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Summary

Unlock all the news: Be the first to know and act before the market!

Maxim Downgrades ZIVO Bioscience to Hold From Buy	Jun. 04	MT
ZIVO BIOS : Quarterly Results (Excel)	May. 13	PU
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07	BU
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07	CI
ZIVO Bioscience Announces Uplisting to OTCQB Market	Jan. 29	BU
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	Jan. 23	CI
ZIVO Bioscience, Inc. announced that it has received $0.531142 million in funding	Jan. 15	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.531142 million in funding	Jan. 03	CI
ZIVO Bioscience, Inc. announced that it has received $0.308936 million in funding	Dec. 26	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.308936 million in funding	Dec. 11	CI
ZIVO Bioscience, Inc. announced that it has received $0.2 million in funding	Dec. 04	CI
ZIVO Bioscience, Inc.(NasdaqCM:ZIVO) dropped from S&P TMI Index	Nov. 29	CI
ZIVO Bioscience, Inc.(OTCPK:ZIVO) dropped from NASDAQ Composite Index	Nov. 24	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.15 million in funding	Nov. 15	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	23-10-30	MT
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-10-30	BU
Reverse Split: 1 of 6	23-10-26	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Summary

Filters